Sunteți pe pagina 1din 6

6/26/2016

PediatricAttentionDeficitHyperactivityDisorder(ADHD):PracticeEssentials,Background,Pathophysiology

PediatricAttentionDeficitHyperactivityDisorder
(ADHD)
Author:MaggieAWilkes,MDChiefEditor:CarolyPataki,MDmore...
Updated:Apr07,2016

PracticeEssentials
Attentiondeficithyperactivitydisorder(ADHD)isadevelopmentalconditionof
inattentionanddistractibility,withorwithoutaccompanyinghyperactivity.

Signsandsymptoms
AccordingtotheDiagnosticandStatisticalManualofMentalHealthDisorders,Fifth
Edition(DSM5),the3typesofattentiondeficit/hyperactivitydisorder(ADHD)are
(1)predominantlyinattentive,(2)predominantlyhyperactive/impulsive,and(3)
combined.ThecurrentDSM5criteriaareprovidedbelow. [1]
Inattentive
Thismustincludeatleast6ofthefollowingsymptomsofinattentionthatmusthave
persistedforatleast6monthstoadegreethatismaladaptiveandinconsistentwith
developmentallevel:
Oftenfailstogivecloseattentiontodetailsormakescarelessmistakesin
schoolwork,work,orotheractivities
Oftenhasdifficultysustainingattentionintasksorplayactivities
Oftendoesnotseemtolistentowhatisbeingsaid
Oftendoesnotfollowthroughoninstructionsandfailstofinishschoolwork,
chores,ordutiesintheworkplace(notduetooppositionalbehaviororfailure
tounderstandinstructions)
Oftenhasdifficultiesorganizingtasksandactivities
Oftenavoidsorstronglydislikestasks(suchasschoolworkorhomework)that
requiresustainedmentaleffort
Oftenlosesthingsnecessaryfortasksoractivities(schoolassignments,
pencils,books,tools,ortoys)
Ofteniseasilydistractedbyextraneousstimuli
Oftenforgetfulindailyactivities
Hyperactivity/impulsivity
Thismustincludeatleast6ofthefollowingsymptomsofhyperactivityimpulsivity
thatmusthavepersistedforatleast6monthstoadegreethatismaladaptiveand
inconsistentwithdevelopmentallevel:
Fidgetingwithortappinghandsorfeet,squirminginseat
Leavingseatinclassroomorinothersituationsinwhichremainingseatedis
expected
Runningaboutorclimbingexcessivelyinsituationswherethisbehavioris
inappropriate(inadolescentsoradults,thismaybelimitedtosubjective
feelingsofrestlessness)
Difficultyplayingorengaginginleisureactivitiesquietly
Unabletobeoruncomfortablebeingstillforextendedperiodsoftime(may
beexperiencedbyothersasonthegoordifficulttokeepupwith)
Excessivetalking
Blurtingoutanswerstoquestionsbeforethequestionshavebeencompleted
Difficultywaitinginlinesorawaitingturningamesorgroupsituations
Interruptingorintrudingonothers(foradolescentsandadults,mayintrude
intoortakeoverwhatothersaredoing)
Other
Onsetisnolaterthanage12years
Symptomsmustbepresentin2ormoresituations,suchasschool,work,or
home
Thedisturbancecausesclinicallysignificantdistressorimpairmentinsocial,
academic,oroccupationalfunctioning
Disorderdoesnotoccurexclusivelyduringthecourseofschizophreniaor
otherpsychoticdisorderandisnotbetteraccountedforbymood,anxiety,
dissociative,personalitydisorderorsubstanceintoxicationorwithdrawal
SeeClinicalPresentationformoredetail.

Diagnosis
PsychometricandeducationaltestingisoftenimportantforthediagnosisofADHD.
Thepatient'sinitialhistorymayindicateaneedforadditionaltests,asfollows:

http://emedicine.medscape.com/article/912633overview

1/6

6/26/2016

PediatricAttentionDeficitHyperactivityDisorder(ADHD):PracticeEssentials,Background,Pathophysiology

ExaminechildrenbyusingtheConners'ParentandTeacherRatingScale
andexamineadolescentsaccordingtotheBrownAttentionDeficitDisorder
Scale(BADDS)forAdolescentsandAdults [2]
Assessimpulsivityandinattentionusingtimedcomputertestssuchasthe
ConnersContinuousPerformanceTest(CPT),theIntegratedVisualand
Auditory(IVA)CPT,orboth
AssessgirlsusingtheNadeau/Quinn/LittmanADHDSelfRatingScalefor
Girls
Assessthepatient'sexecutivefunctionbyusingvariousneuropsychological
tests
Performalearningdisabilityevaluation(intelligencequotient[IQ]vs
achievement)
SeeWorkupformoredetail.

Management
Behavioralandpharmaceuticalstrategiesarethe2majorcomponentsinthe
medicalcareofpatientswithADHD.
Behavioralinterventions
Behavioralpsychotherapyofteniseffectivewhenusedincombinationwith
medication. [3,4]Behavioraltherapyormodificationprogramscanhelpdiminish
uncertainexpectationsandincreaseorganization.Workingwithparentsandschools
throughbehavioralparenttrainingandbehavioralclassroommanagementtoensure
environmentsareconducivetofocusandattentionisnecessary.
Medicationregimens
PsychostimulantsareeffectiveinpatientswithADHD.However,complianceisan
issue,particularlyinchildren.Therefore,theuseoflongactingmedicationsatonce
adaydosingtotreatADHDhasbeenshowntohaveadvancesovershorteracting
drugs.Theirusehasbeenmarkedtohigherratesofremissionandbetter
adherence,andtheyhavebeendemonstratedtobelessstigmatizing.
SeeTreatmentandMedicationformoredetail.

Background
Thetermattentiondeficitismisleading.Ingeneral,thecurrentpredominating
theoriessuggestthatpersonswithattentiondeficithyperactivitydisorder(ADHD),
attentiondeficitdisorder(ADD),actuallyhavedifficultyregulatingtheirattention
inhibitingtheirattentiontononrelevantstimuli,and/orfocusingtoointenselyon
specificstimulitotheexclusionofwhatisrelevant.Inonesense,ratherthantoo
littleattention,manypersonswithADHD(ADD)paytoomuchattentiontotoomany
things,leadingthemtohavelittlefocus.
ThreebasicformsofADHD(ADD)aredescribedintheDiagnosticandStatistical
ManualofMentalDisorders,FifthEdition(DSM5)oftheAmericanPsychiatric
Association(APA). [1]Theyare(1)predominantlyinattentive,(2)predominantly
hyperactive/impulsive,and(3)combined.
Themajorneurologicfunctionsdisturbedbytheneurotransmitterimbalanceof
ADHD(ADD)fallintothecategoryofexecutivefunction.The6majortasksof
executivefunctionthataremostcommonlydistortedwithADHD(ADD)include(1)
shiftingfromonemindsetorstrategytoanother(ie,flexibility),(2)organization(eg,
anticipatingbothneedsandproblems),(3)planning(eg,goalsetting),(4)working
memory(ie,receiving,storing,thenretrievinginformationwithinshortterm
memory),(5)separatingaffectfromcognition(ie,detachingone'semotionsfrom
one'sreason),and(6)inhibitingandregulatingverbalandmotoricaction(eg,
jumpingtoconclusionstooquickly,difficultywaitinginlineinanappropriate
fashion).
Contrarytosomemediaaccounts,ADHD(ADD)isnotnew.Intheearly1900s,
diagnosisemphasizedthehyperactivitycomponent.Today,hyperactivity,impulsivity,
andinattentionaretheareasoffocus.However,reportshavealludedtodisorders
involvinghyperactivity,impulsivity,andinattentioninconjunctionwithdistractibility
andinappropriatearousalpatternsthroughoutmedicalhistory.Whatisnewisthe
enhancedawarenessofADHD(ADD)secondarytorapidlyaccumulatingresearch
findingsanditsadditiontotheDSMin1980.

Pathophysiology
Findingsfromneuropsychologicalstudiessuggestthatthefrontalcortexandthe
circuitslinkingthemtothebasalgangliaarecriticalforexecutivefunctionand,
therefore,toattentionandexercisinginhibition.Manyfindingssupportthisview,
includingthosedescribedbelow.
Executivefunctionsaremajortasksofthefrontallobes.MRIoftherightmesial
prefrontalcortexinpersonswithADHD(ADD)stronglysupportsdecreased
activation(lowarousal)duringtasksthatrequireinhibitionofaplannedmotor
responseandtimingofamotorresponsetoasensorycue.MRIinpersonswith
ADHD(ADD)alsostronglysupportsweakenedactivityintherightinferiorprefrontal
cortexandleftcaudateduringataskthatinvolvestimingofamotorresponsetoa
sensorycue.

http://emedicine.medscape.com/article/912633overview

2/6

6/26/2016

PediatricAttentionDeficitHyperactivityDisorder(ADHD):PracticeEssentials,Background,Pathophysiology

Inanefforttoexploreneuralcorrelatesthatmediateresponseinhibitiondeficitsin
childrenwithADHD,Spinelli,etal(2011)examinedfunctionalMRIbrainactivation
patternsofchildrenaged813yearswithandwithoutADHDonago/nogotask.
Whilelapsesinattentionprecededresponseinhibitionerrorsinthechildrenwithout
ADHD,braincircuitryinvolvedinresponseselectionandcontrolwasactivatedprior
toerrorsinthechildrenwithADHD. [5]
Thecatecholaminesarethemainneurotransmitterswithfrontallobefunction.
Catecholaminecontrolleddopaminergicandnoradrenergicneurotransmission
appeartobethemaintargetsformedicationsusedtotreatADHD(ADD).
A10yearstudybyNationalInstituteofMentalHealth(NIMH)demonstratedthat
thebrainsofchildrenandadolescentswithADHD(ADD)are34%smallerthan
thoseofchildrenwithoutthedisorder,andthatpharmacologictreatmentisnotthe
cause.Themoreseverepatients'ADHD(ADD)symptomswere,asratedbyparents
andclinicians,thesmallertheirfrontallobes,temporalgraymatter,caudate
nucleus,andcerebellumwere.
Datafrom357healthysubjects,obtainedfromtheNIHMRIStudyofNormalBrain
Development,notedthatathinnercortexandslowercorticalthinningwas
associatedwithhigherattentionproblemscores,suggestingalinkbetween
attentionandcorticalmaturation. [6]
Inadditiontotheroleoftheneurotransmittersmostcommonlyassociatedwiththe
frontallobesandthepathwaysmentionedabove,someinvestigationshavebegun
exploringapossiblerolefor5hydroxytryptamine(5HT).Althoughthebrainsmotor
regionsareinnervatedby5HTprojections,noconnectionbetween5HTandADHD
(ADD)motorpathologyhasyetbeenidentified.However,connectionshavebeen
madetoattentionrelatedprocesses.Altered5HTactivitydoesappeartobeat
leastpartofthecausefordifficultieswithperceptualsensitivityandtheappropriate
recognitionoftherelativesignificanceofstimulation.

Epidemiology
Frequency
UnitedStates
TheprevalenceofADHD(ADD)inchildrenappearstobe37%.ADHD(ADD)is
associatedwithsignificantpsychiatriccomorbidity.Approximately5060%of
individualswiththisdisordermeetDSM5criteriaforatleastoneofthepossible
coexistingconditions,whichincludelearningdisorders,restlesslegssyndrome,
ophthalmicconvergenceinsufficiency,depression,anxietydisorders,antisocial
personalitydisorder,substanceabusedisorder,andconductdisorder.Thelikelihood
ofapersonhavingADHD(ADD)ifafamilymemberhasADHD(ADD)oroneofthe
disorderscommonlyassociatedwithADHD(ADD)issignificant.
International
PeoplewithADHD(ADD)havebeenidentifiedineverycountrystudied,with
comparablefrequency.

Mortality/Morbidity
ThemorbidityforADHD(ADD)widelyvaries.Thisrangeisafunctionofmany
factors,includingthespecificareaofdeficit,thepatient'senvironmentalresponseto
andinteractionwiththedeficits,thetherapyprovided,andthepresenceof
coexistentconditions.

Sex
ADHD(ADD)ismorefrequentlydiagnosedinboysthaningirls.Mostestimatesof
themaletofemaleratiorangebetween3:1and4:1inclinicpopulations.However,
manycommunitybasedsamplesproducearatioof2:1.RecognitionofADHD
(ADD)hasimprovedoverthelastdecade,andthemaletofemaleratiohasbeen
decreasingthismaybetheresultoftheincreasedrecognitionofinattentiveADHD
(ADD).

Age
DataconcerningthelikelihoodthatachildwithADHD(ADD)willalsohavethe
disorderasanadultareconflicting.AsdefinitionsofADHD(ADD)subtypes
improve,somesubtypesthatcausemoreadultdysfunctionthanotherswilllikelybe
found.
Approximately3080%ofchildrenwithADHD(ADD)havethedisorderasadults.
Mostexpertsbelievethattherateiswellabove50%.
Hyperactivesymptomsmaydecreasewithagebecauseofdevelopmentaltrends
towardselfcontrolandchangesinbraincomposition(ie,pruningofabundantneural
connections)thatoccurduringlateadolescence.However,personswithADHD
(ADD)developmentallymaturelaterthantheaveragepopulation.Inattentive
symptomsdonotappeartohaveasimilardevelopmentaladvantageandtendto
remainconstantintoadulthood.
ClinicalPresentation

http://emedicine.medscape.com/article/912633overview

3/6

6/26/2016

PediatricAttentionDeficitHyperactivityDisorder(ADHD):PracticeEssentials,Background,Pathophysiology

ContributorInformationandDisclosures
Author
MaggieAWilkes,MDResidentPhysician,DepartmentofPsychiatry,MedicalUniversityofSouthCarolina
CollegeofMedicine
MaggieAWilkes,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofChildand
AdolescentPsychiatry,AmericanMedicalAssociation,AmericanPsychiatricAssociation
Disclosure:Nothingtodisclose.
Coauthor(s)
EveGSpratt,MD,MScProfessorofPediatricsandPsychiatry,DivisionofDevelopmentalPediatrics,Medical
UniversityofSouthCarolinaDirector,PediatricConsultationLiaisonPsychiatry,MedicalUniversityofSouth
CarolinaChildren'sHospitalatCharleston
EveGSpratt,MD,MScisamemberofthefollowingmedicalsocieties:AmericanAcademyofChildand
AdolescentPsychiatry
Disclosure:Nothingtodisclose.
StaceyMCobb,MDFellowinDevelopmentalandBehavioralPediatrics,ClinicalInstructor,Departmentof
Pediatrics,MedicalUniversityofSouthCarolinaCollegeofMedicine
StaceyMCobb,MDisamemberofthefollowingmedicalsocieties:AlphaOmegaAlpha,AmericanAcademyof
Pediatrics,SocietyforDevelopmentalandBehavioralPediatrics
Disclosure:Nothingtodisclose.
ChiefEditor
CarolyPataki,MDHealthSciencesClinicalProfessorofPsychiatryandBiobehavioralSciences,Universityof
California,LosAngeles,DavidGeffenSchoolofMedicine
CarolyPataki,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofChildandAdolescent
Psychiatry,NewYorkAcademyofSciences,PhysiciansforSocialResponsibility
Disclosure:Nothingtodisclose.
Acknowledgements
ZainabPContractor,MDMedicalDirector,TheAffinityCenter
Disclosure:Nothingtodisclose.
ChetJohnson,MDProfessorandChairofPediatrics,AssociateDirector,DevelopmentalPediatrician,Center
forChildHealthandDevelopment,ShiefelbuschInstituteforLifeSpanStudies,UniversityofKansasSchoolof
MedicineLENDDirector,UniversityofKansasMedicalCenter
ChetJohnson,MDisamemberofthefollowingmedicalsocieties:AmericanAcademyofPediatrics
Disclosure:Nothingtodisclose.
ChristineAMayhall,PhDClinicalPsychologist,TheAffinityCenter
ChristineAMayhall,PhDisamemberofthefollowingmedicalsocieties:AmericanPsychologicalAssociation
Disclosure:Nothingtodisclose.
MaryLWindle,PharmDAdjunctAssociateProfessor,UniversityofNebraskaMedicalCenterCollegeof
PharmacyEditorinChief,MedscapeDrugReference
Disclosure:Nothingtodisclose.

References
1.AmericanPsychiatricAssociation.DiagnosticandStatisticalManualofMentalDisorders,FifthEdition.
Washington,DC:AmericanPsychiatricAssociation2013.
2.BrownTE.BrownADDScales.SanAntonio,TX:PsychologicalCorp1996:56.
3.DaleyD,vanderOordS,FerrinM,etal,fortheEuropeanADHDGuidelinesGroup.Behavioral
interventionsinattentiondeficit/hyperactivitydisorder:ametaanalysisofrandomizedcontrolledtrials
acrossmultipleoutcomedomains.JAmAcadChildAdolescPsychiatry.2014Aug.53(8):835847.e5.
[Medline].
4.BrauserD.BehavioralinterventionseffectiveforADHD.MedscapeMedicalNews.July31,2014.[Full
Text].
5.SpinelliS,JoelS,NelsonTE,VasaRA,PekarJJ,MostofskySH.Differentneuralpatternsareassociated
withtrialsprecedinginhibitoryerrorsinchildrenwithandwithoutattentiondeficit/hyperactivitydisorder.J
AmAcadChildAdolescPsychiatry.2011Jul.50(7):705715.e3.[Medline].
6.DucharmeS,HudziakJJ,BotteronKN,AlbaughMD,NguyenTV,KaramaS,etal.Decreasedregional
corticalthicknessandthinningrateareassociatedwithinattentionsymptomsinhealthychildren.JAm
AcadChildAdolescPsychiatry.2012Jan.51(1):1827.e2.[Medline].[FullText].
7.FDA.FDAPermitsMarketingofFirstBrainWaveTestToHelpAssessChildrenandTeensforADHD.US
FoodandDrugAdministration.Jul152013.Availableat
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm360811.htm.

http://emedicine.medscape.com/article/912633overview

4/6

6/26/2016

PediatricAttentionDeficitHyperactivityDisorder(ADHD):PracticeEssentials,Background,Pathophysiology

8.LowesR.FirstBrainWaveTestforADHDApprovedbyFDA.MedscapeMedicalNews.Jul152013.[Full
Text].
9.NiggJT,LewisK,EdingerT,FalkM.Metaanalysisofattentiondeficit/hyperactivitydisorderorattention
deficit/hyperactivitydisordersymptoms,restrictiondiet,andsyntheticfoodcoloradditives.JAmAcadChild
AdolescPsychiatry.2012Jan.51(1):8697.e8.[Medline].
10.MelvilleN.ADHDMedsMayDoubleCardiovascularEventRiskinKids.MedscapeMedicalNews.
Availableathttp://www.medscape.com/viewarticle/827747..Accessed:July6,2014.
11.DalsgaardS,KvistAP,LeckmanJF,NielsenHS,SimonsenM.CardiovascularSafetyofStimulantsin
ChildrenwithAttentionDeficit/HyperactivityDisorder:ANationwideProspectiveCohortStudy.JChild
AdolescPsychopharmacol.2014Jun23.[Medline].
12.CasselsC.ADHDMedsLinkedtoPriapism,PromptsFDAWarning,LabelChange.Medscape[serial
online].Availableathttp://www.medscape.com/viewarticle/817936.Accessed:December21,2013.
13.Pfizer.PfizerReceivesU.S.FDAApprovalofNewQuilliChewER(methylphenidatehydrochloride)
extendedreleasechewabletabletsCII.Availableathttp://www.pfizer.com/news/pressrelease/press
release
detail/pfizer_receives_u_s_fda_approval_of_new_quillichew_er_methylphenidate_hydrochloride_extended_release_chewable_tablets_cii?
linkId=19384409.December7,2015Accessed:December7,2015.
14.Brauser,D.FDAapprovesADHDdrugformaintenancetreatmentinkids.MedscapeMedicalNews.May2,
2013.Availableathttp://www.medscape.com/viewarticle/803516.Accessed:May13,2013.
15.BladerJC,SchoolerNR,JensenPS,PliszkaSR,KafantarisV.Adjunctivedivalproexversusplacebofor
childrenwithADHDandaggressionrefractorytostimulantmonotherapy.AmJPsychiatry.2009Dec.
166(12):1392401.[Medline].[FullText].
16.HabelLA,CooperWO,SoxCM,ChanKA,FiremanBH,ArbogastPG,etal.ADHDmedicationsandrisk
ofseriouscardiovasculareventsinyoungandmiddleagedadults.JAMA.2011Dec28.306(24):267383.
[Medline].[FullText].
17.WilensTE,BuksteinO,BramsM,CutlerAJ,ChildressA,RuginoT,etal.Acontrolledtrialofextended
releaseguanfacineandpsychostimulantsforattentiondeficit/hyperactivitydisorder.JAmAcadChild
AdolescPsychiatry.2012Jan.51(1):7485.e2.[Medline].
18.DoyleK.MethylphenidateReducesInjuriesinKidsWithADHD.MedscapeMedicalNews.Availableat
http://www.medscape.com/viewarticle/836933.Accessed:December20,2014.
19.ManKK,ChanEW,CoghillD,DouglasI,IpP,LeungLP,etal.MethylphenidateandtheRiskofTrauma.
Pediatrics.2014Dec15.[Medline].
20.EliaJ,AmbrosiniPJ,RapoportJL.Treatmentofattentiondeficithyperactivitydisorder.NEnglJMed.
1999Mar11.340(10):7808.[Medline].
21.AdisetiyoV,JensenJH,TabeshA,DeardorffRL,FieremansE,DiMartinoA,etal.MultimodalMR
ImagingofBrainIroninAttentionDeficitHyperactivityDisorder:ANoninvasiveBiomarkerThatResponds
toPsychostimulantTreatment?.Radiology.2014Jun17.140047.[Medline].
22.BrauserD.ToomuchTVlinkedtoaggression,inattentioninkids.MedscapeMedicalNews.Availableat
http://www.medscape.com/viewarticle/772099.Accessed:October15,2012.
23.BrooksM.EyeTestMayDiagnoseADHD,PredictTreatmentResponse.MedscapeMedicalNews.
Availableathttp://www.medscape.com/viewarticle/830188.Accessed:August23,2014.
24.BrooksM.MoreThanSymptomsatPlayinPrescribingADHDMedstoKids.MedscapeMedicalNews.Oct
172014.[FullText].
25.BrooksM.BrainIronLevelsaPotentialADHDBiomarker.Available.MedscapeMedicalNews.Availableat
http://www.medscape.com/viewarticle/826896.Accessed:June26,2014.
26.FriedM,TsitsiashviliE,BonnehYS,SterkinA,WygnanskiJaffeT,EpsteinT,etal.ADHDsubjectsfailto
suppresseyeblinksandmicrosaccadeswhileanticipatingvisualstimulibutrecoverwithmedication.Vision
Res.2014Aug.101:6272.[Medline].
27.GalraC,PingaultJB,MichelG,etal.Clinicalandsocialfactorsassociatedwithattentiondeficit
hyperactivitydisordermedicationuse:populationbasedlongitudinalstudy.BrJPsychiatry.2014Oct.
205(4):2917.[Medline].
28.HandL.StimulantslinkedtolowersmokingriskinkidswithADHD.MedscapeMedicalNews.May14,
2014.[FullText].
29.HuntRD,PaguinA,PaytonK.Anupdateonassessmentandtreatmentofcomplexattentiondeficit
hyperactivitydisorder.PediatrAnn.2001Mar.30(3):16272.[Medline].
30.JohnsonTM.Evaluatingthehyperactivechildinyouroffice:isitADHD?.AmFamPhysician.1997Jul.
56(1):15560,16870.[Medline].
31.MillichapJG.Etiologicclassificationofattentiondeficit/hyperactivitydisorder.Pediatrics.2008Feb.
121(2):e35865.[Medline].
32.NadeauKG,LittmanE,QuinnP.UnderstandingGirlsWithAD/HD.Springfield,MD:AdvantageBooks
2000.
33.RamchandaniP,JoughinC,ZwiM.Attentiondeficithyperactivitydisorderinchildren.ClinEvid.2002Jun.
26271.[Medline].
34.RappleyMD.Clinicalpractice.Attentiondeficithyperactivitydisorder.NEnglJMed.2005Jan13.
352(2):16573.[Medline].

http://emedicine.medscape.com/article/912633overview

5/6

6/26/2016

PediatricAttentionDeficitHyperactivityDisorder(ADHD):PracticeEssentials,Background,Pathophysiology

35.ReevesG,SchweitzerJ.Pharmacologicalmanagementofattentiondeficithyperactivitydisorder.Expert
OpinPharmacother.2004Jun.5(6):131320.[Medline].
36.SchoenfelderEN,FaraoneSV,KollinsSH.StimulantTreatmentofADHDandCigaretteSmoking:A
MetaAnalysis.Pediatrics.2014May12.[Medline].
37.SpencerTJ,BiedermanJ,WilenT.PharmacotherapyofADHDwithantidepressants.In:BarkleyRS,ed.
AttentionDeficitHyperactivityDisorder:AHandbookforDiagnosisandTreatment.2nded.NewYork,NY:
GuilfordPress1998:55263.
38.VerlindenM,TiemeierH,HudziakJJ,JaddoeVW,RaatH,GuxensM,etal.Televisionviewingand
externalizingproblemsinpreschoolchildren:theGenerationRStudy.ArchPediatrAdolescMed.2012
Oct.166(10):91925.[Medline].
39.WilensTE.StraightTalkaboutPsychiatricMedicationsforKids.NewYork,NY:GuilfordPress2002.
40.WolraichML,ed.TheClassificationofChildandAdolescentMentalDiagnosesinPrimaryCare:Diagnostic
andStatisticalManualforPrimaryCare(DSMPC)Child.ElkGrove,IL:AmericanAcademyofPediatrics
1996.

MedscapeReference2011WebMD,LLC

http://emedicine.medscape.com/article/912633overview

6/6

S-ar putea să vă placă și